David B. Nyer

The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells

Karmella A. Haynes, Kimberly C. Olney, David B. Nyer, 2018, BMC Systems Biology.

Harnessing type I CRISPR–Cas systems for genome engineering in human cells

Leslie S. Edwards, Stan J. J. Brouns, David B. Nyer, 2019, Nature Biotechnology.

Regulation of cancer epigenomes with a histone-binding synthetic transcription factor

David B. Nyer, Daniel A. Vargas, K. Haynes, 2016, bioRxiv.

The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells

Kimberly C. Olney, David B. Nyer, Daniel A. Vargas, 2018 .

Activation of tumor suppressor genes in breast cancer cells by a synthetic chromatin effector

Kimberly C. Olney, David B. Nyer, Melissa A. Wilson Sayres, 2017, bioRxiv.

Regulation of cancer epigenomes with a histone-binding synthetic transcription factor

David B. Nyer, Daniel A. Vargas, K. Haynes, 2016, npj Genomic Medicine.

Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.

David B. Nyer, A. May, M. Jinek, 2021, Molecular cell.